ClinicalTrials.gov
ClinicalTrials.gov Menu

Bioequivalence Study of Ondansetron Orally Disintegrating Tablets 8mg Under Fed Conditions

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01523119
Recruitment Status : Completed
First Posted : February 1, 2012
Last Update Posted : February 9, 2012
Sponsor:
Information provided by (Responsible Party):
Ranbaxy Inc. ( Ranbaxy Laboratories Limited )

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 2006
  Actual Study Completion Date : October 2006